The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity
Abstract
β‐Amyloid (Aβ), a major constituent of senile plaques in Alzheimer's disease (AD), is thought to contribute to the neurodegeneration. We examined the effects of nicotinic receptor agonists on Aβ cytotoxicity in cultured rat cortical neurons. The number of viable neurons decreased significantly when cultures were exposed to synthetic Aβ peptides (25–35). Concomitant administration of nicotine with Aβ markedly reduced the number of dead cells. This nicotine‐induced neuroprotection was dependent on the concentration. When hexamethonium or mecamylamine, nicotinic antagonist, was added, neuroprotective effect of nicotine was blocked, which indicates that effect of nicotine was mediated by nicotinic receptors. In addition, a selective α7‐receptor antagonist, α‐bungarotoxin (α‐BTX), blocked the neuroprotective effect of nicotine. Furthermore, incubation with 3–(2,4)‐dimethoxybenzylidene anabaseine (DMXB), a selective α7–receptor agonist, protected against Aβ‐induced neuronal death. These results suggest that α7–receptor activation plays an important role in neuroprotection against Aβ cytotoxicity. This study suggests that nicotinic receptor stimulation, especially α‐receptor activation, may be able to protect neurons from degeneration induced by Aβ and may have effects that counter the progress of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Seguela, P., Wadiche, J., Dineley-Miller, K., Dani, J., & Patrick, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Clarke, P., Schwartz, R., Paul, S., Pert, C., & Pert, A. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01307.1985 · Cited by 1,036
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,030
Couturier, S., Bertrand, D., Matter, J.-M., Hernandez, M.-C., Bertrand, S., Millar, N., Valera, S., Barkas, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 828
Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Perry, E. K., Morris, C. M., Court, J. A., Cheng, A., Fairbairn, A. F., McKeith, I. G., Irving, D., Brown, A., & Perry, R. H. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00410-7 · Cited by 386
Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors
Deneris, E. S., Connolly, J., Rogers, S. W., & Duvoisin, R. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90486-c · Cited by 318
Nicotinic receptors that bind α-bungarotoxin on neurons raise intracellular free ca2+
Vijayaraghavan, S., Pugh, P. C., Zhang, Z.-W., Rathouz, M. M., & Berg, D. K. (1992) · Neuron · doi:10.1016/0896-6273(92)90301-s · Cited by 264
Changes in Nicotinic and Muscarinic Cholinergic Receptors in Alzheimer‐Type Dementia
Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb12960.x · Cited by 257
Self-citationZhang, Z.-W., Vijayaraghavan, S., & Berg, D. K. (1994) · Neuron · doi:10.1016/0896-6273(94)90161-9 · Cited by 252
Akaike, A., Tamura, Y., Yokota, T., Shimohama, S., & Kimura, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91678-0 · Cited by 240
Self-citationA mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans
Treinin, M., & Chalfie, M. (1995) · Neuron · doi:10.1016/0896-6273(95)90231-7 · Cited by 203
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M., & Brenneman, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.427 · Cited by 181
Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor
Gopalakrishnan, M., Buisson, B., Touma, E., Giordano, T., Campbell, J. E., Hu, I. C., Donnelly-Roberts, D., Arneric, S. P., Bertrand, D., & Sullivan, J. P. (1995) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(95)00083-6 · Cited by 172
Nerve growth factor potentiates the neurotoxicity of beta amyloid.
Yankner, B. A., Caceres, A., & Duffy, L. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.9020 · Cited by 171
A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus
Hunter, B. E., de Fiebre, C. M., Papke, R. L., Kem, W. R., & Meyer, E. M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90433-2 · Cited by 160
Le, W., Colom, L. V., Xie, W., SMITH, R. G., Alexianu, M. E., & Appel, S. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00450-5 · Cited by 147
Shimohama, S., AKAIKE, A., & Kimura, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34445.x · Cited by 131
Self-citationAlkondon, M., Reinhardt, S., Lobron, C., Hermsen, B., Maelicke, A., & Albuquerque, E. X. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22712-4 · Cited by 113
Marin, P., Maus, M., Desagher, S., Glowinski, J., & Prémont, J. (1994) · Neuroreport · doi:10.1097/00001756-199410000-00035 · Cited by 110
Tamura, Y., Sato, Y., Akaike, A., & Shiomi, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91691-7 · Cited by 87
Self-citationMartin, E. J., Panickar, K. S., King, M. A., Deyrup, M. D., Hunter, B. E., Wang, G., & Meyer, E. M. (1994) · Drug Development Research · doi:10.1002/ddr.430310208 · Cited by 76
Shimohama, S., Ogawa, N., Tamura, Y., Akaike, A., Tsukahara, T., Iwata, H., & Kimura, J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91164-n · Cited by 69
Self-citationPerry, G. L., Cras, P. P., Siedlak, S. L., Tabaton, M., & Kawai, M. (1992) · PubMed Central · Cited by 66
β-Amyloid 25–35 activates nitric oxide synthase in a neuronal clone
Hu, J., & El‐Fakahany, E. E. (1993) · Neuroreport · doi:10.1097/00001756-199306000-00041 · Cited by 40
Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study
Nelson, P. T., Marton, L. S., & Saper, C. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)91385-6 · Cited by 33
Cited by
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
Arundine, M., & Tymianski, M. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00141-6 · Cited by 820
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782
Metadata
- Authors
- Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., & Akaike, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1997-08
- Volume
- 42
- Issue
- 2
- Pages
- 159-163
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1994121039
- Cited by
- 321
- References
- 34
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.